Want to see CVS full AI Analyst Report?
CVS Stock Chart & Stats
$77.30
-$0.04(-0.09%)
At close: 4:00 PM EST
$77.30
-$0.04(-0.09%)
Day’s Range― - ―
52-Week Range$58.50 - $108.97
Previous CloseN/A
Volume5.40M
Average Volume (3M)8.00M
Market Cap
$137.12B
Enterprise Value$158.57K
Total Cash (Recent Filing)$11.80B
Total Debt (Recent Filing)$78.34B
Price to Earnings (P/E)46.5
Beta0.50
Next Earnings
Aug 05, 2026EPS Estimate
1.83Next Dividend Ex-DateN/A
Dividend Yield2.48%
Share Statistics
EPS (TTM)2.31
Shares Outstanding1,275,927,200
10 Day Avg. Volume7,724,097
30 Day Avg. Volume8,004,127
Financial Highlights & Ratios
PEG Ratio-0.92
Price to Book (P/B)1.34
Price to Sales (P/S)0.25
P/FCF Ratio12.88
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$110.13Price Target Upside42.46% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering17
EPS Forecast (FY)7.44
Revenue Forecast (FY)$409.03B
Bulls Say, Bears Say
Bulls Say
Vertical Integration & ScaleCVS’s integrated model (Health Care Benefits, PBM, retail pharmacy) creates durable synergies: it can steer pharmacy volume to owned channels, cross-sell services, and coordinate care management. This structural advantage supports steady revenue capture, retention and cost control over months to years.
Strong Cash GenerationConsistent operating and free cash flow provide CVS with durable financial flexibility to fund clinical investments, technology/AI rollouts, debt reduction and dividends. Reliable FCF cushions earnings volatility and supports strategic initiatives without relying on equity financing.
Aetna Margin RecoveryMaterial AOI improvement and a much-improved medical benefit ratio signal structural progress in the insurance business. A sustained margin recovery at Aetna reduces enterprise medical cost risk, strengthens predictable underwriting economics and supports longer-term profitability.
Bears Say
Profitability CompressionSharply lower margins and returns reflect persistent cost and pricing pressure across segments. Even with scale, compressed profitability limits reinvestment capacity, weakens returns to shareholders and makes achieving prior ROE levels a multi-year challenge absent structural margin improvement.
PBM Margin & Rebate PressureRebate guarantees, client price concessions and shifting drug mix structurally reduce PBM spreads and HSS operating income. Persistent contract pressures constrain a historically high-margin cash engine, making PBM profit recovery uncertain and creating downside to long-term cash flow.
Membership Loss & Regulatory UncertaintyExiting the Individual Exchange reduced membership scale and premium revenue, weakening network leverage and underwriting diversification. Combined with state-level regulatory fragmentation, this raises structural uncertainty over enrollment, access and reimbursement dynamics across markets over the medium term.
CVS Health News
CVS FAQ
What was CVS Health Corp’s price range in the past 12 months?
CVS Health Corp lowest stock price was $58.50 and its highest was $108.97 in the past 12 months.
What is CVS Health Corp’s market cap?
CVS Health Corp’s market cap is $137.12B.
When is CVS Health Corp’s upcoming earnings report date?
CVS Health Corp’s upcoming earnings report date is Aug 05, 2026 which is in 16 days.
How were CVS Health Corp’s earnings last quarter?
CVS Health Corp released its earnings results on May 06, 2026. The company reported $2.57 earnings per share for the quarter, beating the consensus estimate of $2.184 by $0.386.
Is CVS Health Corp overvalued?
According to Wall Street analysts CVS Health Corp’s price is currently Undervalued.
Does CVS Health Corp pay dividends?
CVS Health Corp pays a Quarterly dividend of $0.665 which represents an annual dividend yield of 2.48%. See more information on CVS Health Corp dividends here
What is CVS Health Corp’s EPS estimate?
CVS Health Corp’s EPS estimate is 1.83.
How many shares outstanding does CVS Health Corp have?
CVS Health Corp has 1,275,927,200 shares outstanding.
What happened to CVS Health Corp’s price movement after its last earnings report?
CVS Health Corp reported an EPS of $2.57 in its last earnings report, beating expectations of $2.184. Following the earnings report the stock price went up 7.647%.
Which hedge fund is a major shareholder of CVS Health Corp?
Currently, no hedge funds are holding shares in CVS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CVS Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$110.13 (42.46% Upside)
$110.13 (42.46% Upside)
Blogger Sentiment
Bullish
CVS Sentiment 70%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Decreased
By 18.9M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $323.7M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 0.7%
Last 30 Days ▲ 1.7%
Last 30 Days ▲ 1.7%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
75.98%
12-Months-Change
Fundamentals
Return on Equity
2.48%
Trailing 12-Months
Asset Growth
-1.02%
Trailing 12-Months
Company Description
CVS Health Corp
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
CVS Revenue Breakdown
46.57% Health Services
35.05% Health Care Benefits
33.40% Pharmacy & Consumer Wellness
0.12% Corporate/ Other
CVS Stock 12 Month Forecast
Average Price Target
$110.13
▲(42.46% Upside)
Technical Analysis
Ownership Overview
0.41% Insiders
32.79% Mutual Funds
0.90% Other Institutional Investors
44.63% Public Companies and Individual Investors